The fund has sold its stake in Crispr for $60.25. Reasons for the sale are below. We still believe in the valuable work in Crispr. It is more a financial decision than anything else. We will continue to monitor its progress.
- Crispr hit a target of $60.00 far quicker than the fund believed could happen.
- Other opportunities within the biosciences sector have been found.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Monday, May 11, 2020
Sunday, May 10, 2020
May 4-8 Performance (Crispr, Microvision, Hive Blockchain, Social Capital, Fuel Cell Energy)
Here are some metrics and notes for the week of May 4-8.
- Sold position in Microvision. Story link here.
- Started position in Fuel Cell Energy. Story link here.
- Bitcoin is back around $10,000 with halving coming up later this month (affecting Hive Blockchain position).
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
| Security/Project | Type | Date of Purchase | Cost of Investment | Current Value | Return % |
| Crispr Therapeutics | Stock | 3/23/2020 | $38.78 | 53.81 | 38.76% |
| Hive Blockchain | Stock | 4/16/2020 | $0.16 | 0.33 | 106.25% |
| Social Capital | Stock | 5/1/2020 | $10.20 | 10.34 | 1.37% |
| Fuel Cell Energy | Stock | 5/3 | $1.93 | 2.1 | 8.81% |
- Sold position in Microvision. Story link here.
- Started position in Fuel Cell Energy. Story link here.
- Bitcoin is back around $10,000 with halving coming up later this month (affecting Hive Blockchain position).
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Tuesday, May 5, 2020
Purchased Shares of Fuel Cell
The fund has purchased shares of Fuel Cell Energy. We purchased the shares for $1.93. We do not have a plan to sell the shares.
Fuel Cell Energy has a mission of "Delivering clean innovative solutions for the global supply, recovery and storage of energy.".
We are excited to own shares of this company as it is providing an innovative, tested, valuable process that can help with climate change. We believe the new management is starting to execute on its plans. They have strong partners both domestically, and internationally. The market is wide open with opportunity.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Fuel Cell Energy has a mission of "Delivering clean innovative solutions for the global supply, recovery and storage of energy.".
We are excited to own shares of this company as it is providing an innovative, tested, valuable process that can help with climate change. We believe the new management is starting to execute on its plans. They have strong partners both domestically, and internationally. The market is wide open with opportunity.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Monday, May 4, 2020
Sold Remaining Microvision Shares
With some surprise, Microvision's stock price hit our target. With another opportunity staring at us, we have decided to sell the remaining shares at $0.94. The total profit for the 2 months the shares were held was over 300%. This was not expected.
Proceeds will go to taxes, KeaneVCC charity, investors and the rest will be put back into the account.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Proceeds will go to taxes, KeaneVCC charity, investors and the rest will be put back into the account.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Labels:
Charity,
KDK Fund,
KeaneVCC,
Microvision,
Profits
Portfolio Weekly Performance (Crispr, Microvision, Hive Blockchain, Social Capital)
Here are some metrics and some activity notes.
- Crispr released earnings this past week. Story link can be found here.
- Sold 1/2 of Microvision stock. Story here.
- Microvision releasing earnings this week.
- Bought Social Capital. Story here.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
| Security/Project | Type | Date of Purchase | Cost of Investment | Current Value | Return % | Notes |
| Crispr Therapeutics | Stock | 3/23/2020 | $38.78 | 54.01 | 39.27% | |
| Microvision | Stock | 3/23/2020 | $0.00 | 0.44 | 100.00% | Sold Cost portion. All Profit at this point |
| Hive Blockchain | Stock | 4/16/2020 | $0.16 | 0.23 | 43.75% | |
| Social Capital | Stock | 5/1/2020 | $10.20 | 10.19 | -0.10% |
- Crispr released earnings this past week. Story link can be found here.
- Sold 1/2 of Microvision stock. Story here.
- Microvision releasing earnings this week.
- Bought Social Capital. Story here.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Friday, May 1, 2020
New Position in Social Capital
A new position has been started in Social Capital (symbol IPOB.U). The fund paid $10.20 for each unit. There is no plan to sell the stake and a strong motivation to keep adding to the position.
Social Capital's mission is "to advance humanity by solving the world’s hardest problems". Who doesn't like that mission ;)? In some seriousness, they are a driven company with an exceptional CEO (Samath Palihapitiya). The market value of the companies they invest in have yet to be quantified. KDK Fund expects this stake to keep producing positive results (financial and otherwise) for decades to come. Their website can be found here.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Social Capital's mission is "to advance humanity by solving the world’s hardest problems". Who doesn't like that mission ;)? In some seriousness, they are a driven company with an exceptional CEO (Samath Palihapitiya). The market value of the companies they invest in have yet to be quantified. KDK Fund expects this stake to keep producing positive results (financial and otherwise) for decades to come. Their website can be found here.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
1/2 Position in Microvision Sold
The fund has sold 1/2 of its position in Microvision. Some of the reasons are below.
- The price of Microvision rose to $0.40.
- Selling 1/2 the position protects capital, leaving the rest as profit
- There are other opportunities for the capital
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Subscribe to:
Posts (Atom)